Posted 5/15/2023 4:27 PM (GMT 0)
05/18/2009 - Robot-assisted laparoscopic radical prostatectomy
Surgical Pathology: Prostate gland 51.8 grams; Gleason score 3+3=6; Pathologic stage T2c, N0, Mx; Left/Right Pelvic lymph nodes clear (no tumor present); No presence of extra-capsular invasion; No margin involvement
07/06/2009 - 1st post-surgery PSA <0.1.
PSA started creeping up slowly around 2013 and hit 0.20 in early 2017.
Relatively stable during 2019, 2020 and 2021:
03/15/19 - 0.30
06/22/19 - 0.34
09/10/19 - 0.36
02/24/20 - 0.34
07/17/20 - 0.33
12/22/20 - 0.37
03/08/21 - 0.35
09/03/21 - 0.36
Jumped up in late 2021 but has remained relatively stable since:
11/17/21 - 0.51
03/07/22 - 0.53
10/08/22 - 0.54
01/17/23 - 0.56
05/01/23 - 0.63
PSA doubling time is still 2-3 years on average.
So far, no post-surgery treatment, just periodic PSA monitoring.
3/9/2023 - PSMA PET-CT Ga68 scan:
1. No convincing evidence of distant PSMA-avid metastases.
2. Head/Neck: There is no pathologically enlarged or PSMA-avid lymph node.
3. Chest: Mediastinum, hila and lymph nodes: There is no pathologically enlarged or PSMA-avid lymph node.
4. Abdomen: There is no pathologically enlarged or PSMA-avid lymph node.
5. Pelvis:
a. Lymph nodes: There is no pathologically enlarged or PSMA-avid lymph node.
b. Soft tissue: Status post radical prostatectomy. There is a 0.9 cm focus of intense PSMA uptake in the prostate bed, adjacent to the left posteroinferior bladder wall, corresponding to an ill-defined soft tissue nodule on CT (SUV max 40.5, average Hounsfield units 50, 4:81, 3:47).
4/26/23 - MRI scan:
1. Prostate size: Status post prostatectomy. Corresponding to focus of PSMA avidity in the left prostatectomy bed, there is a 0.9 x 0.4 cm nodule (series 6, image 18), which demonstrates marked diffusion restriction and early enhancement.
2. Seminal vesicles: Unremarkable
3. Neurovascular bundles: Uninvolved.
4. Urethra (including bladder inlet and urogenital diaphragm): Unremarkable
5. Lymph nodes: No lymphadenopathy.
6. Urinary bladder: Underdistention is associated with mild, uniform bladder wall thickening.
7. Bowel and peritoneum: No ascites
8. Osseous structures: No aggressive lesions.
9. Anterior pelvic wall: No inguinal hernia.
All of my statistics point to a non-aggressive, or indolent, cancer. My question is this: if my PSA continues to rise slowly, with a consistent doubling time of over two years, does the cancer ever need to be treated? Does a Gleason 3+3 remain a 3+3 forever, meaning it's something that I never need to worry about? Does the existence of a "nodule" mean that the cancer is no longer indolent? Are the conclusions different when the situation is biochemical recurrence? What if my life expectancy is 120?